ABSTRACT Background. The optimal preoperative a-blockade strategy is debated for patients undergoing laparoscopic adrenalectomy for pheochromocytomas. We evaluated the impact of selective versus non-selective a-blockade on intraoperative hemodynamics and postoperative outcomes. Methods. We identified patients having laparoscopic adrenalectomy for pheochromocytomas from 2001 to 2015. As a marker of overall intraoperative hemodynamics, we combined systolic blood pressure (SBP) [ 200, SBP \ 80, SBP \ 80 and [200, pulse [ 120, vasopressor infusion, and vasodilator infusion into a single variable. Similarly, the combination of vasopressor infusion in the post-anesthesia care unit (PACU) and the need for intensive care unit (ICU) admission provided an overview of postoperative support. Results. We identified 52 patients undergoing unilateral laparoscopic adrenalectomy for pheochromocytoma. Selective a-blockade (i.e. doxazosin) was performed in 35 % (n = 18) of patients, and non-selective blockade with phenoxybenzamine was performed in 65 % (n = 34) of patients. Demographics and tumor characteristics were similar between groups. Patients blocked selectively were more likely to have an SBP \ 80 (67 %) than those blocked with phenoxybenzamine (35 %) (p = 0.03), but we found no significant difference in overall intraoperative hemodynamics between patients blocked selectively and non-selectively (p = 0.09). However, postoperatively, patients blocked selectively were more likely to require additional support with vasopressor infusions in the PACU or ICU admission (p = 0.02). Hospital stay and complication rates were similar. Conclusion. Laparoscopic adrenalectomy for pheochromocytoma is safe regardless of the preoperative a-blockade strategy employed, but patients blocked selectively may have a higher incidence of transient hypotension during surgery and a greater need for postoperative support. These differences did not result in longer hospital stay or increased complications.
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Pheochromocytomas are rare catecholamine-secreting tumors that usually originate in the adrenal medulla. Surgical extirpation is curative, but can be associated with rapid and severe blood pressure fluctuations in the operating room. Laparoscopic adrenalectomy, first described in the early 1990s, is associated with less pain, less morbidity, and a quicker recovery, and is considered the gold-standard surgery for benign adrenal lesions. [1] [2] [3] [4] [5] Intraoperative hemodynamic instability during adrenalectomy for pheochromocytomas places patients at significantly increased risk for major morbidity. 6 a-Receptor blockade and volume expansion are the mainstays of preoperative preparation in order to help minimize intraoperative instability, or at least make catecholamine fluctuations easier to control; 7 however, the optimal ablockade strategy is debated. 8 Phenoxybenzamine provides irreversible inhibition of both a-1 and a-2 receptors, and although its half-life is 24 h, it requires administration two to three times daily because new receptors are constantly being produced. Non-selectively blocked patients often experience more side effects, such as nasal congestion and inhibition of postural reflexes, resulting in orthostatic hypotension. Selective a-1 receptor blockade with newer agents such as doxazosin provides an alternative. Although the half-life is similar (22 h), sustained-release formulations allow once-daily administration. Selective a-1 blockers cause fewer side effects, which are largely driven by a-2 inhibition; however, their inhibition is competitive and may be overcome with large surges in catecholamines, especially during manipulation of a pheochromocytoma. Therefore, selective blockade may not offer as much protection against perioperative hemodynamic instability as non-competitive blockade.
Previous studies have evaluated the impact of selective versus non-selective a-blockade on intraoperative and postoperative outcomes but these investigations have many limitations. For instance, some studies compared groups of patients undergoing mixed proportions of laparoscopic and open adrenalectomy [9] [10] [11] and others failed to correct for tumor size variations between groups. 9, 12 Another study examined outcomes across two institutions with different practices and populations. 13 In order to minimize confounding variables, we compared outcomes across two similar populations receiving the same operation. We aimed to compare the effects of selective versus non-selective a-blockade on intraoperative hemodynamic instability and postoperative support requirements in patients exclusively undergoing laparoscopic adrenalectomy for pheochromocytoma.
METHODS
We performed a retrospective comparative cohort study of patients undergoing adrenalectomy from 2001 to 2015 at a single institution. We identified patients in a prospectively maintained adrenal database, and the University of Wisconsin Institutional Review Board approved the study. Patients with histologically confirmed pheochromocytomas were included. Planned open (n = 2) and bilateral (n = 1) adrenalectomies were excluded, and one patient who underwent a reoperative laparoscopic adrenalectomy following a prior partial adrenalectomy was also excluded. Patients were categorized into two groups based on preoperative a-blockade strategy. We compared patients blocked selectively with those blocked non-selectively with phenoxybenzamine. We examined patient and tumor characteristics, intraoperative hemodynamics, and postoperative outcomes between groups.
All patients were a-blocked prior to adrenalectomy. Selective a-blockade included terazosin, prazosin, and doxazosin, and non-selective a-blockade consisted only of phenoxybenzamine. a-Blockade initiated prior to surgical referral was continued with the same agent. Alternatively, patients were started on an a-blocker at the discretion of the operating surgeon. For those initiated on a-blockade by the surgeon, the starting dose was either phenoxybenzamine 10 mg three times daily or doxazosin 1-2 mg daily. Following initiation of a-blockade with either selective or non-selective agents, doses were titrated to blood pressures of 120/80 mmHg. Additionally, patients receiving phenoxybenzamine were titrated to the point of developing orthostatic hypotension, which suggested loss of the baroreceptor reflex and achievement of complete blockade. This side effect was not experienced with selective blockade. After a-blockade was achieved, a b-blocker added additional heart rate control when necessary. Hydration and increased salt intake was encouraged the week before surgery. Adequate a-blockade, based on measured blood pressure, was required before adrenalectomy.
In the operating room, all patients received an arterial line for blood pressure monitoring, and indwelling urinary catheters to measure urine output. The anesthesiologist established access with at least two well-functioning peripheral intravenous lines. Central access was left to the discretion of the anesthesiologist. Once monitoring and access was sufficient, a transabdominal laparoscopic adrenalectomy was performed. Anesthesiologists determined the thresholds for treating patient hemodynamics and decided whether to use fluid or vasoactive drugs. At the conclusion of surgery, vasopressors were weaned as soon as physiologically safe. Patients recovered in the postanesthesia care unit (PACU) prior to admission to the general ward. Admission to the intensive care unit (ICU) only occurred when patient physiology, hemodynamic monitoring, and hospital policy demanded a higher level of care.
Patient and tumor characteristics were recorded prospectively. Intraoperative hemodynamic profiles were retrospectively abstracted from anesthesia records. Anesthesia records at our institution do not record specific systolic blood pressures (SBP) above 200 mmHg, therefore any SBP [ 200 mmHg was considered to be 200 mmHg for the purpose of calculating the SBP range intraoperatively. When estimated blood loss was recorded as 'minimal', we assigned it a value of 0 mL.
The primary outcome was intraoperative hemodynamic instability, while the secondary outcome was postoperative support. As a marker of overall intraoperative hemodynamic instability, we created a composite variable, Selective a-blockade was performed in 35 % (n = 18) of cases, while non-selective blockade with phenoxybenzamine was performed in 65 % (n = 34) of cases. The majority of the first 26 patients (92 %) were blocked non-selectively, while the majority of the second 26 patients (62 %) were blocked selectively. The selectively blocked group included 12 (66.7 %) patients prepared with doxazosin, 5 (27.8 %) patients prepared with prazosin, and 1 (5.6 %) patient prepared with terazosin. Age, sex, Charlson Comorbidity Index, 14 body mass index, tumor laterality, tumor size, and hormone profiles were similar between the two groups ( Table 1) . Tumor sizes ranged from 1 to 9.5 cm.
Operative time was similar between groups (median, 99 min for selective blockade versus 93 min for non-selective blockade; p = 0.99), as was estimated blood loss (median, 40 mL for selective blockade versus 100 mL for non-selective blockade; p = 0.08). Intraoperatively, the initial, highest, and lowest SBP were similar between groups (Table 2) . Although patients blocked selectively were no more likely to have an SBP [ 200 mmHg during the case (27.8 % for selective blockade vs. 20.6 % for nonselective blockade; p = 0.56), they were more likely to have their SBP drop below 80 mmHg than those blocked with phenoxybenzamine (66.7 % for selective blockade vs. 35.3 % for non-selective blockade; p = 0.03). Although there was variation in the amounts of crystalloid and colloid fluids administered, urine output was similar between groups (median output 313 mL for selective blockade vs. 200 for non-selective blockade; p = 0.14), indicating similar volume status. When evaluating intraoperative hemodynamic instability as a single variable, the overall hemodynamic profiles revealed that the two blockade strategies did not result in significantly different instability (Fig. 1) .
Postoperatively, patients recovered well, requiring little support. The median length of stay was 1 day for both groups (p = 0.18). Although most patients were weaned from vasopressor infusions prior to leaving the operating room, a minority of patients required vasopressors in recovery (Table 3) . When we examined vasopressor requirements in the recovery room and the need for ICU admission as a single variable, analysis revealed that patients blocked selectively required more postoperative support (Fig. 2 ). Overall complication rates were similar between groups (11.1 % for selective blockade vs. 11.8 % for non-selective blockade; p = 0.94). Seven complications were noted in six patients, and included respiratory insufficiency (n = 2), pneumonia (n = 1), pneumothorax (n = 1), bleeding from the liver (n = 1), splenic injury (n = 1), and delirium (n = 1).
DISCUSSION
Laparoscopic adrenalectomy for pheochromocytomas is safe but the optimal preoperative a-receptor blockade strategy is controversial. Prior studies on this topic compared heterogeneous groups and dissimilar practices. The current study investigated the impact of selective versus non-selective a-blockade on perioperative outcomes in patients with pheochromocytomas who underwent laparoscopic adrenalectomy. Both groups were similar in terms of patient demographics, comorbidities, and tumor characteristics. Additionally, patients in each group appeared to be completely and similarly a-blocked prior to surgery based on their initial intraoperative blood pressures. Overall, intraoperative hemodynamics were not significantly different between the two groups. Patients blocked selectively required slightly more postoperative support, but this requirement did not translate into increased complications or a longer length of stay.
In the current study, intraoperative hypertensive episodes (SBP [ 200 mmHg) occurred in a similar proportion of patients in both groups. Several prior studies have also shown no difference in intraoperative hypertensive episodes or peak SBP during tumor handling. 9, 10, 12 On the other hand, Weingarten and colleagues 13 reported that the total intraoperative time spent at pressures above 200 mmHg did not differ between groups, but they did demonstrate that the mean peak SBP was significantly greater for the group blocked selectively. However, this study compared patients at two different institutions, and selective blockade was more common in a patient population with a higher body mass index. 13 Yet others have also reported more episodes of intraoperative hypertension in patients blocked selectively.
11, 15 Zhu and colleagues 16 reported higher, but not hypertensive, mean SBP during anesthesia in patients blocked selectively, but blood pressures during tumor handling were similar. 16 The current study may have had insufficient numbers to identify increased hypertensive episodes in selectively blocked patients, but the lack of a noted difference could also reflect the exclusion of confounding variables. Other major predictors of hypertensive episodes have included open procedures and large tumor size, 15 and the current study did not include open procedures and tumor size was equivalent between groups.
Another difference we found compared with prior studies was a higher proportion of patients who experienced hypotensive episodes (SBP \ 80 mmHg) in the selectively blocked group. We also noted a greater range of intraoperative SBPs in the selectively blocked group. In contrast, Zhu and colleagues 16 reported a wider range of intraoperative SBP in non-selectively blocked patients. 16 The reason for the increased hypotensive episodes and greater intraoperative SBP variability is not readily apparent. Because the number of patients was small, it is possible that hypotensive episodes appeared more common in selectively blocked patients due to the impact of outliers or confounding factors. Based on the intraoperative fluid requirements and urine output, patients appeared similarly well-hydrated. Patients blocked selectively also did not have greater estimated blood loss to explain more hypotensive episodes. Besides hydration status and blood loss, another possible confounding factor is anesthesiologist bias. Perhaps anesthesiologists were more concerned about hypertensive episodes in patients blocked selectively, and treated higher blood pressures more aggressively. However, we did not see more liberal use of vasodilator infusions in the selectively blocked group, suggesting that if a treatment bias is present, it is small. Despite the increase in hypotensive episodes, wider range of intraoperative SBPs, and non-significant trends in other individual operative hemodynamic parameters, our data demonstrate that, overall, hemodynamic instability was not significantly different for each preoperative ablockade strategy. This conclusion is based on the similarity between the composite variable that took several markers of hemodynamic instability into account. Our findings are in agreement with many others who have failed to identify a difference in overall hemodynamic instability based on the type of preoperative blockade. 9, 10, 12 In contrast, our results disagree with other investigations that report improved intraoperative stability with phenoxybenzamine. 11, 13, 15 After a thorough review of previously published studies on the subject, van der Zee and de Boer (8) concluded that no clearly superior ablockade strategy exists; however, they do suggest that intraoperative hemodynamics appear to be slightly more stable in patients blocked non-selectively. 8 In our study, patients generally did very well postoperatively, regardless of the type of a-blockade. When considering the combination of vasopressor support in the recovery room and ICU admission as a marker of postoperative support, our data demonstrate that patients blocked selectively needed slightly more support. In spite of the increased support requirements, hospital stays were equally short and complications few when compared with the nonselectively blocked group. Many other studies have also been unable to show a difference in postoperative outcomes based on preoperative a-blockade strategy, even when intraoperative hemodynamics were different. [9] [10] [11] [12] [13] 15 Collectively, the current study and the existing literature fail to demonstrate the superiority of one strategy over the other in terms of operative outcomes. In patients having their pheochromocytomas resected laparoscopically, either strategy appears to be a safe option. In the absence of a clearly safer a-blockade strategy, secondary considerations such as convenience, patient tolerance, and cost are important considerations in the choice of agent. Selective a-blockers are administered less frequently and are generally tolerated without side effects. Furthermore, 30 tablets (1-month supply) of doxazosin range between $7 and $30, but 30 capsules (10-15-day supply) of phenoxybenzamine range from $7100 to $7600, yet the cost of the medication may not reflect the entirety of the cost implications of each strategy. 17 The current study does have limitations. First, despite having a relatively large number of patients with a rare disease, the sample remains small. The size of the groups precluded subgroup and multivariate analyses. Furthermore, we may have been underpowered to detect real differences in individual hemodynamic parameters as there were several non-significant trends noted between the two groups. To combat this limitation and to provide an overview of hemodynamic instability, a composite variable was constructed and compared between groups. Additionally, the retrospective nature of the study made it impossible to determine why a particular a-blocker was chosen over another. The choice of a-blockade was based on what the referring provider had initiated, or on surgeon preference, instead of being based on patient characteristics, but selection biases may be present. Lastly, the current study only evaluated patients undergoing laparoscopic adrenalectomy, therefore our results might not be generalizable to patients having open adrenalectomies. Despite these limitations, this study represents a single institution comparative cohort study of a-blockade strategies in a homogeneous population undergoing adrenalectomy with a similar technique.
CONCLUSIONS
Our results demonstrate that laparoscopic adrenalectomy for pheochromocytoma is safe regardless of the ablockade strategy employed, but patients blocked selectively may have a higher incidence of transient hypotension during surgery and require slightly more postoperative support. While these differences did not result in a longer hospital stay or increased complications, they serve to caution surgeons against the widespread adoption of selective a-blockade without further investigation.
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